These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11585357)

  • 1. Regional and hormone-dependent effects of apolipoprotein E genotype on changes in bone mineral in perimenopausal women.
    Gerdes LU; Vestergaard P; Hermann AP; Mosekilde L
    J Bone Miner Res; 2001 Oct; 16(10):1906-16. PubMed ID: 11585357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?
    Heikkinen AM; Kröger H; Niskanen L; Komulainen MH; Ryynänen M; Parviainen MT; Tuppurainen MT; Honkanen R; Saarikoski S
    Maturitas; 2000 Jan; 34(1):33-41. PubMed ID: 10687880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women.
    Efstathiadou Z; Koukoulis G; Stakias N; Challa A; Tsatsoulis A
    Maturitas; 2004 Jul; 48(3):259-64. PubMed ID: 15207892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial.
    Recker RR; Davies KM; Dowd RM; Heaney RP
    Ann Intern Med; 1999 Jun; 130(11):897-904. PubMed ID: 10375338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premenopausal smoking and bone density in 2015 perimenopausal women.
    Hermann AP; Brot C; Gram J; Kolthoff N; Mosekilde L
    J Bone Miner Res; 2000 Apr; 15(4):780-7. PubMed ID: 10780870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional association between bone mineral density and parathyroid hormone and other biomarkers in community-dwelling young adults: the CARDIA study.
    Fujiyoshi A; Polgreen LE; Hurley DL; Gross MD; Sidney S; Jacobs DR
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4038-46. PubMed ID: 23966240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
    Ooms ME; Lips P; Roos JC; van der Vijgh WJ; Popp-Snijders C; Bezemer PD; Bouter LM
    J Bone Miner Res; 1995 Aug; 10(8):1177-84. PubMed ID: 8585420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women.
    Vestergaard P; Hermann AP; Gram J; Jensen LB; Eiken P; Abrahamsen B; Brot C; Kolthoff N; Sørensen OH; Beck Nielsen H; Pors Nielsen S; Charles P; Mosekilde L
    Maturitas; 2001 Dec; 40(3):211-20. PubMed ID: 11731182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women--implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study.
    Abrahamsen B; Stilgren LS; Hermann AP; Tofteng CL; Bärenholdt O; Vestergaard P; Brot C; Nielsen SP
    J Bone Miner Res; 2001 Jul; 16(7):1212-9. PubMed ID: 11450696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study.
    Vestergaard P; Hermann AP; Orskov H; Mosekilde L
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2286-90. PubMed ID: 10404791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank.
    Ambikairajah A; Khondoker M; Morris E; de Lange AG; Saleh RNM; Minihane AM; Hornberger M
    Hum Brain Mapp; 2024 Feb; 45(2):e26612. PubMed ID: 38339898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gender and age on the association of apolipoprotein E epsilon4 with bone mineral density, bone turnover and the risk of fractures in older people.
    Pluijm SM; Dik MG; Jonker C; Deeg DJ; van Kamp GJ; Lips P
    Osteoporos Int; 2002 Sep; 13(9):701-9. PubMed ID: 12195533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ; Chesnut CH; Mallinak NJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women.
    Saadi HF; Nagelkerke N; Benedict S; Qazaq HS; Zilahi E; Mohamadiyeh MK; Al-Suhaili AI
    Bone; 2006 Nov; 39(5):1136-1143. PubMed ID: 16814623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons.
    Kuchuk NO; Pluijm SM; van Schoor NM; Looman CW; Smit JH; Lips P
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1244-50. PubMed ID: 19158198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.